{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T18:52:44Z","timestamp":1782240764803,"version":"3.54.5"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["71173245"],"award-info":[{"award-number":["71173245"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81473065"],"award-info":[{"award-number":["81473065"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"DOI":"10.3389\/fpubh.2019.00327","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:08:47Z","timestamp":1573517327000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["The Decade-Long Chinese Methadone Maintenance Therapy Yields Large Population and Economic Benefits for Drug Users in Reducing Harm, HIV and HCV Disease Burden"],"prefix":"10.3389","volume":"7","author":[{"given":"Lei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Medland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwei","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,11,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/s10461-015-1113-z","article-title":"HIV, Hepatitis C, and abstinence from alcohol among injection and non-injection drug users","volume":"20","author":"Elliott","year":"2016","journal-title":"AIDS Behav."},{"key":"B2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1080\/10550887.2011.642755","article-title":"Assessment of risky injection practices associated with Hepatitis B, Hepatitis C, and human immunodeficiency virus and using the blood-borne virus transmission risk assessment questionnaire","volume":"31","author":"Reynolds","year":"2012","journal-title":"J Addict Dis."},{"key":"B3","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.drugalcdep.2013.08.017","article-title":"Interventions to prevent the initiation of injection drug use: a systematic review","volume":"133","author":"Werb","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"B4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.drugpo.2005.02.008","article-title":"Effectiveness of drug dependence treatment in HIV prevention","volume":"16","author":"Farrell","year":"2005","journal-title":"Int J Drug Policy."},{"key":"B5","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1097\/01.aids.0000327439.20914.33","article-title":"The role of harm reduction in controlling HIV among injecting drug users","volume":"22","author":"Wodak","year":"2008","journal-title":"AIDS."},{"key":"B6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3109\/10826084.2014.957768","article-title":"Methadone maintenance therapy and HIV counseling and testing are associated with lower frequency of risky behaviors among injection drug users in China","volume":"50","author":"Wang","year":"2015","journal-title":"Subst Use Misuse."},{"key":"B7","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/S0140-6736(07)60315-8","article-title":"Evolution of China's response to HIV\/AIDS","volume":"369","author":"Wu","year":"2007","journal-title":"Lancet."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e13484","DOI":"10.5812\/ircmj.13484","article-title":"The long-term effectiveness of methadone maintenance treatment in prevention of Hepatitis C virus among illicit drug users: a modeling study","volume":"16","author":"Javanbakht","year":"2014","journal-title":"Iran Red Crescent Med J."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e7801","DOI":"10.5812\/ircmj.7801","article-title":"Cost-effectiveness of methadone maintenance treatment in prevention of HIV among drug users in Shiraz, South of Iran","volume":"16","author":"Keshtkaran","year":"2014","journal-title":"Iran Red Crescent Med J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"e008162","DOI":"10.1136\/bmjopen-2015-008162","article-title":"Trends and risk factors for HIV, HCV and syphilis seroconversion among drug users in a methadone maintenance treatment programme in China: a 7-year retrospective cohort study","volume":"5","author":"Zou","year":"2015","journal-title":"BMJ Open."},{"key":"B11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.drugpo.2013.08.004","article-title":"What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010\u20132012? A review of the six highest burden countries","volume":"25","author":"Degenhardt","year":"2014","journal-title":"Int J Drug Policy"},{"key":"B12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1747-597X-9-23","article-title":"Differential long-term outcomes for voluntary and involuntary transition from injection to oral opioid maintenance treatment","volume":"9","author":"Oviedo-Joekes","year":"2014","journal-title":"Subst Abus Treat Prev Policy."},{"key":"B13","volume-title":"Reducing Harm, Preventing HIV, Saving Lives: China's Vast Methadone Maintenance Treatment Program Marks Successes Even as it Addresses Key Challenges Ahead","year":"2014"},{"key":"B14","doi-asserted-by":"publisher","first-page":"ii29","DOI":"10.1093\/ije\/dyq210","article-title":"Scaling up the national methadone maintenance treatment program in China: achievements and challenges","volume":"39","author":"Yin","year":"2010","journal-title":"Int J Epidemiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e68906","DOI":"10.1371\/journal.pone.0068906","article-title":"Methadone maintenance treatment participant retention and behavioural effectiveness in China: a systematic review and meta-analysis","volume":"8","author":"Zhang","year":"2013","journal-title":"PloS ONE."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e12411","DOI":"10.5812\/hepatmon.12411","article-title":"Effectiveness of methadone maintenance treatment in prevention of Hepatitis C virus transmission among injecting drug users","volume":"13","author":"Alavian","year":"2013","journal-title":"Hepatitis Mon."},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1000423","DOI":"10.1371\/journal.pmed.1000423","article-title":"Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine","volume":"8","author":"Alistar","year":"2011","journal-title":"PLoS Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"S39","DOI":"10.1093\/cid\/cit296","article-title":"Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy","volume":"57","author":"Martin","year":"2013","journal-title":"Clin Infect Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.drugalcdep.2012.02.021","article-title":"Cost-effectiveness of integrating methadone maintenance and antiretroviral treatment for HIV-positive drug users in Vietnam's injection-driven HIV epidemics","volume":"125","author":"Tran","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1984","DOI":"10.1111\/j.1360-0443.2012.03932.x","article-title":"Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in Hepatitis C virus prevalence? Model projections for different epidemic settings","volume":"107","author":"Vickerman","year":"2012","journal-title":"Addiction."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1007\/s10461-011-0131-8","article-title":"A review of the literature on event-level substance use and sexual risk behavior among men who have sex with men","volume":"16","author":"Vosburgh","year":"2012","journal-title":"AIDS Behav."},{"key":"B22","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.drugpo.2012.06.009","article-title":"Cost-effectiveness of methadone maintenance therapy as HIV prevention in an Indonesian high-prevalence setting: a mathematical modeling study","volume":"23","author":"Wammes","year":"2012","journal-title":"Int J Drug Policy."},{"key":"B23","first-page":"333","article-title":"Modeling the costs and effects of maintenance treatment for opiate addiction","volume-title":"Operations Research and Health Care: A Handbook of Methods and Applications","author":"Zaric","year":"2004"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.2105\/AJPH.90.7.1100","article-title":"HIV transmission and the cost-effectiveness of methadone maintenance","volume":"90","author":"Zaric","year":"2000","journal-title":"Am J Public Health."},{"key":"B25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.drugalcdep.2010.03.006","article-title":"Optimal targeting of Hepatitis C virus treatment among injecting drug users to those not enrolled in methadone maintenance programs","volume":"110","author":"Zeiler","year":"2010","journal-title":"Drug Alcohol Depend."},{"key":"B26","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1155\/2014\/527030","article-title":"Factors associated with spontaneous clearance of Hepatitis C virus in Chinese population","volume":"2014","author":"Kong","year":"2014","journal-title":"BioMed Res Int."},{"key":"B27","doi-asserted-by":"publisher","first-page":"S58","DOI":"10.1016\/j.jhep.2014.07.012","article-title":"Natural history of hepatitis C","volume":"61","author":"Westbrook","year":"2014","journal-title":"J Hepatol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/hep.27406","article-title":"The global burden of liver disease: the major impact of China","volume":"60","author":"Wang","year":"2014","journal-title":"Hepatology."},{"key":"B29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00535-012-0669-x","article-title":"Host factors determining the efficacy of hepatitis C treatment","volume":"48","author":"Chuang","year":"2013","journal-title":"J Gastroenterol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1097\/MCG.0000000000000109","article-title":"Current challenges and the management of chronic hepatitis C in mainland China","volume":"48","author":"Duan","year":"2014","journal-title":"J Clin Gastroenterol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e19616","DOI":"10.1371\/journal.pone.0019616","article-title":"A Bayesian framework for parameter estimation in dynamical models","volume":"6","author":"Coelho","year":"2011","journal-title":"PloS ONE."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1080\/01621459.2000.10474324","article-title":"Inference for deterministic simulation models: the Bayesian Melding Approach","volume":"95","author":"Poole","year":"2000","journal-title":"J Am Stat Assoc."},{"key":"B33","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S0140-6736(11)60842-8","article-title":"The role of acute and early HIV infection in the spread of HIV and implications for transmission prevention strategies in Lilongwe, Malawi: a modelling study","volume":"378","author":"Powers","year":"2011","journal-title":"Lancet."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1111\/j.1360-0443.2012.03859.x","article-title":"Misconceptions predict dropout and poor adherence prospectively among newly admitted first-time methadone maintenance treatment clients in Guangzhou, China","volume":"107","author":"Gu","year":"2012","journal-title":"Addiction."},{"key":"B35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/ijpp.12049","article-title":"Does training in motivational interviewing for community pharmacists improve outcomes for methadone patients? A cluster randomised controlled trial","volume":"22","author":"Jaffray","year":"2014","journal-title":"Int J Pharm Pract."},{"key":"B36","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.drugalcdep.2013.06.021","article-title":"Time to first treatment interruption in the Chinese methadone maintenance treatment programme","volume":"133","author":"Sullivan","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"B37","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s11481-016-9665-x","article-title":"Drug abuse, HIV, and HCV in Asian Countries","volume":"11","author":"Hser","year":"2016","journal-title":"J Neuroimmune pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"938","DOI":"10.3760\/cma.j.issn.0253-9624.2014.11.004","article-title":"[Social network analysis and high risk behavior characteristics of recreational drug users: a qualitative study]","volume":"48","author":"Wu","year":"2014","journal-title":"Zhonghua yu fang yi xue za zhi [Chin J Prev Med]."},{"key":"B39","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1007\/s11904-014-0227-7","article-title":"Cost-effectiveness analysis along the continuum of HIV care: how can we optimize the effect of HIV treatment as prevention programs?","volume":"11","author":"Nosyk","year":"2014","journal-title":"Curr HIV\/AIDS Rep."},{"key":"B40","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3109\/9780203414088-12","article-title":"Clinical guidelines and procedures for the use of methadone in the maintenance treatment of opioid dependence","volume-title":"Pharmacotherapies for the Treatment of Opioid Dependence: Efficacy, Cost-Effectiveness and Implementation Guidelines.","author":"Henry-Edwards","year":"2009"},{"key":"B41","doi-asserted-by":"publisher","first-page":"E305","DOI":"10.3390\/ijerph13030305","article-title":"Concurrent heroin use and correlates among methadone maintenance treatment clients: a 12-month follow-up study in Guangdong Province, China","volume":"13","author":"Luo","year":"2016","journal-title":"Int J Env Res Public Health."},{"key":"B42","first-page":"896","article-title":"Effectiveness of relapse prevention cognitive-behavioral model in opioid-dependent patients participating in the methadone maintenance treatment in Iran","volume":"42","author":"Pashaei","year":"2013","journal-title":"Iran J Public Health."},{"key":"B43","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jsat.2013.12.004","article-title":"Continued drug use during methadone treatment in China: a retrospective analysis of 19,026 service users","volume":"47","author":"Sullivan","year":"2014","journal-title":"J Subst Abuse Treat."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e0139942","DOI":"10.1371\/journal.pone.0139942","article-title":"Investigation of repeat client drop-out and re-enrolment cycles in fourteen methadone maintenance treatment clinics in Guangdong, China","volume":"10","author":"Zhang","year":"2015","journal-title":"PloS ONE."},{"key":"B45","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/add.12782","article-title":"Predictors of accessing antiretroviral therapy among HIV-positive drug users in China's National Methadone Maintenance Treatment Programme","volume":"110","author":"Zhao","year":"2015","journal-title":"Addiction."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/j.drugpo.2014.04.021","article-title":"Integrating antiretroviral therapy in methadone maintenance therapy clinics: Service provider perceptions","volume":"25","author":"Lin","year":"2014","journal-title":"Int J Drug Policy."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e0147922","DOI":"10.1371\/journal.pone.0147922","article-title":"Baseline HCV antibody prevalence and risk factors among drug users in China's National Methadone Maintenance Treatment Program","volume":"11","author":"Wang","year":"2016","journal-title":"PloS ONE."},{"key":"B48","unstructured":"China Food and Drug Administration has Approved for the Daclatasvir and Asunaprevir in the Market2017"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpubh.2019.00327\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:08:51Z","timestamp":1573517331000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fpubh.2019.00327\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,12]]},"references-count":48,"alternative-id":["10.3389\/fpubh.2019.00327"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2019.00327","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,12]]},"article-number":"327"}}